![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ingen Technologies Inc (CE) | USOTC:IGNT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
Ingen Medical Product Receives Good Review
RIVERSIDE, CA--(Marketwired - Jun 4, 2014) - Ingen Technologies Inc. (PINKSHEETS: IGNT) submitted a quote for 30,000 Oxyview units this week to their major supplier in New York who serves medical device companies worldwide by providing stock components. Companies purchase from our New York client to eliminate the cost of tooling their own components and to receive immediate delivery from inventory. This particular approach is useful to companies of all sizes, but has proven especially effective for small to mid-range manufacturing companies, as evidenced by their broad customer base cultivated over the years.
"This large request for our respiratory product has broken the ice after years of building strong relationships with our clients and OEM partners," stated Gary Tilden, Chairman. "We are hopeful that Oxyview continues to prove to be a useful and effective respiratory device."
Ingen is a medical device manufacturer of Oxyview products and has sold over 100,000 units worldwide over the past 6 years.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Gary Tilden Chairman 951-688-7840 www.ingen-tech.com
1 Year Ingen Technologies (CE) Chart |
1 Month Ingen Technologies (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions